developed to support advanced research and scientific development
NAD+ IV Therapy delivers NAD+ directly into the bloodstream, bypassing digestion and providing immediate bioavailability
10.1007/s12291-017-0667-0 109
The combined formulation enables researchers to investigate signaling coordination, pathway convergence, and molecular interaction dynamics across multiple metabolic and mitochondrial regulatory systems within controlled laboratory environments
Exosomes, or extracellular nanovesicles, and peptides, small strings of amino acids, have shown promise as topical therapies in early trials, but neither is FDA approved
Each compound is supplied with a comprehensive Certificate of Analysis (COA) providing qualitative and quantitative data to support transparency, traceability, and reproducibility in laboratory environments